These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 10695485)

  • 1. Angiogenesis in ischemic disease.
    Marti HH; Risau W
    Thromb Haemost; 1999 Sep; 82 Suppl 1():44-52. PubMed ID: 10695485
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of the vascular endothelial growth factor isoforms in retinal angiogenesis and DiGeorge syndrome.
    Stalmans I
    Verh K Acad Geneeskd Belg; 2005; 67(4):229-76. PubMed ID: 16334858
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gene transfer for therapeutic vascular growth in myocardial and peripheral ischemia.
    Rissanen TT; Rutanen J; Ylä-Herttuala S
    Adv Genet; 2004; 52():117-64. PubMed ID: 15522734
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Angiogenesis therapy in ischemic disease.
    Silvestre JS; Lévy BI
    Arch Mal Coeur Vaiss; 2002 Mar; 95(3):189-96. PubMed ID: 11998334
    [TBL] [Abstract][Full Text] [Related]  

  • 5. VEGF-D is the strongest angiogenic and lymphangiogenic effector among VEGFs delivered into skeletal muscle via adenoviruses.
    Rissanen TT; Markkanen JE; Gruchala M; Heikura T; Puranen A; Kettunen MI; Kholová I; Kauppinen RA; Achen MG; Stacker SA; Alitalo K; Ylä-Herttuala S
    Circ Res; 2003 May; 92(10):1098-106. PubMed ID: 12714562
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gene therapy progress and prospects: therapeutic angiogenesis for limb and myocardial ischemia.
    Khan TA; Sellke FW; Laham RJ
    Gene Ther; 2003 Feb; 10(4):285-91. PubMed ID: 12595887
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Therapeutic angiogenesis induced by human hepatocyte growth factor gene in rat and rabbit hindlimb ischemia models: preclinical study for treatment of peripheral arterial disease.
    Taniyama Y; Morishita R; Aoki M; Nakagami H; Yamamoto K; Yamazaki K; Matsumoto K; Nakamura T; Kaneda Y; Ogihara T
    Gene Ther; 2001 Feb; 8(3):181-9. PubMed ID: 11313789
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of vascular endothelial growth factor (VEGF) as a novel approach for cancer therapy.
    Wood JM
    Medicina (B Aires); 2000; 60 Suppl 2():41-7. PubMed ID: 11188930
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Changing the logic of therapeutic angiogenesis for ischemic disease.
    Emanueli C; Madeddu P
    Trends Mol Med; 2005 May; 11(5):207-16. PubMed ID: 15882608
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vascular endothelial growth factor (VEGF) and its effect on angiogenesis.
    Jośko J; Gwóźdź B; Jedrzejowska-Szypułka H; Hendryk S
    Med Sci Monit; 2000; 6(5):1047-52. PubMed ID: 11208453
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lymphatic versus blood vascular endothelial growth factors and receptors in humans.
    Partanen TA; Paavonen K
    Microsc Res Tech; 2001 Oct; 55(2):108-21. PubMed ID: 11596156
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ischemic vascular disease and solid cancers: opposing ends of the angiogenic spectrum?
    Balasubramanian SP; Reed MW
    Med Hypotheses; 2006; 67(6):1317-9. PubMed ID: 16828237
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The biology of vascular endothelial growth factors.
    Tammela T; Enholm B; Alitalo K; Paavonen K
    Cardiovasc Res; 2005 Feb; 65(3):550-63. PubMed ID: 15664381
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adeno-associated viral vector-mediated vascular endothelial growth factor gene transfer induces neovascular formation in ischemic heart.
    Su H; Lu R; Kan YW
    Proc Natl Acad Sci U S A; 2000 Dec; 97(25):13801-6. PubMed ID: 11095751
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hepatocyte growth factor as potential cardiovascular therapy.
    Nakagami H; Kaneda Y; Ogihara T; Morishita R
    Expert Rev Cardiovasc Ther; 2005 May; 3(3):513-9. PubMed ID: 15889978
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Therapeutic angiogenesis in peripheral arterial disease: can biotechnology produce an effective collateral circulation?
    Collinson DJ; Donnelly R
    Eur J Vasc Endovasc Surg; 2004 Jul; 28(1):9-23. PubMed ID: 15177227
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Redox signaling in angiogenesis: role of NADPH oxidase.
    Ushio-Fukai M
    Cardiovasc Res; 2006 Jul; 71(2):226-35. PubMed ID: 16781692
    [TBL] [Abstract][Full Text] [Related]  

  • 18. VEGFs and receptors involved in angiogenesis versus lymphangiogenesis.
    Lohela M; Bry M; Tammela T; Alitalo K
    Curr Opin Cell Biol; 2009 Apr; 21(2):154-65. PubMed ID: 19230644
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Non-viral vectors for gene therapy: clinical trials in cardiovascular disease.
    Shah PB; Losordo DW
    Adv Genet; 2005; 54():339-61. PubMed ID: 16096018
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impaired angiogenesis after hindlimb ischemia in type 2 diabetes mellitus: differential regulation of vascular endothelial growth factor receptor 1 and soluble vascular endothelial growth factor receptor 1.
    Hazarika S; Dokun AO; Li Y; Popel AS; Kontos CD; Annex BH
    Circ Res; 2007 Oct; 101(9):948-56. PubMed ID: 17823371
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.